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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
16.06.2020 Effectiveness 
of isolation, 
testing, 
contact 
tracing, and 
physical 
distancing on 
reducing 
transmission 
of SARS-
CoV-2 in 
different 
settings: a 
mathematical 
modelling 
study 
The Lancet 
Infectious 
Diseases | 
Article 
 A study of more than 40 
000 individuals to assess 
contact patterns and 
potential SARS-CoV-2 
transmission in different 
settings and to compare 
how combinations of self-
isolation, contact tracing, 
and physical distancing 
could reduce secondary 
cases. 
 The high transmissibility, 
the relative short serial 
interval and 
asymptomatic 
transmission of SARS-
CoV-2 challenge 
effective isolation and 
contract tracing. This 
analysis estimated that a 
high proportion of cases 
would need to self-isolate 
and a high proportion of 
their contacts to be 
successfully traced to 
ensure an effective 
reproduction number 
Contact 
tracing, self- 
isolation, 
physical 
distancing, 
transmission 
2 
lower than 1 in the 
absence of other 
measures. 
 Combining isolation and 
contact tracing with 
physical distancing 
measures, especially in 
settings where contact 
tracing would be difficult, 
could increase the 
likelihood of achieving 
sustained control of 
SARS-CoV-2 
transmission 
16.06.2020 The potential 
impact of 
COVID-19 in 
refugee 
camps in 
Bangladesh 
and beyond: 
A modelling 
study 
PLoS 
Medicine | 
Article 
 Using a dynamic model 
of SARS-CoV-2 
transmission, authors 
simulated how a C19 
outbreak could spread 
within the expansion site 
according to 3 possible 
transmission scenarios 
(high, moderate, low) 
 Results show that a large 
scale outbreak is very 
likely in this setting after 
a single infectious person 
enters the camp 
 Hospitalisation capacity 
may be exceeded within 
55-136 days after 
introduction 
 Many approaches used 
to prevent and respond 
to C19 will not be 
practical in humanitarian 
settings. Novel and 
untested strategies 
should be considered 
including innovative 
solutions to fill health 
workforce gaps 
Refugee 
camps, 
transmission 
15.06.2020 A novel 
cohort 
analysis 
approach to 
determining 
the case 
fatality rate 
of COVID-19 
and other 
PLoS ONE | 
Article 
 Authors claim that this 
model can be used far 
more effectively than 
current models to 
estimate the CFR during 
an outbreak, allow for 
better planning and to 
better understand the 
impact of individual 
interventions on the CFR 
CFR 
3 
infectious 
diseases 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
16.06.2020 GM-CSF blockade 
with mavrilimumab 
in severe COVID-
19 pneumonia and 
systemic 
hyperinflammation: 
a single-centre, 
prospective cohort 
study 
The Lancet 
Rheumatology 
| Article 
 Treatment with 
mavrilimumab, an 
anti-granulocyte-
macrophage 
colony-stimulating 
factor receptor-a 
monoclonal 
antibody, was 
associated with 
improved clinical 
outcomes 
compared with 
standard care in 
non-mechanically 
ventilated patients 
with severe 
COVID-19 
pneumonia and 
systemic 
hyperinflammation 
 Treatment as well 
tolerated 
 Confirmation of this 
first preliminary 
evidence of a 
treatment effect of 
GM-CSF inhibition 
in COVID-
19  supports further 
investigation 
 mavrilimumab 
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Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
17.06.2020 Understanding the impact of COVID-19 
on essential medicine supply chains 
CGD | Blog Anthony 
McDonnell 
Kalipso 
Chalkidou 
Prashant 
Yadav 
Dan Rosen 
17.06.2020 Global Fund Survey: Majority of HIV, TB 
and malaria programs face disruptions 
as a result of COVID-19 
The Global Fund | 
News 
 
16.06.2020 How deadly is the coronavirus? 
Scientists are close to an answer 
Nature | News Smriti 
Mallapaty 
16.06.2020 Case isolation, contact tracing, and 
physical distancing are pillars of COVID-
19 pandemic control, not optional 
choices 
The Lancet Infectious 
Diseases | Comment 
Chandini 
Raina 
MacIntyre 
16.06.2020 Delivering evidence-based critical care 
for mechanically ventilated patients with 
COVID-19 
The Lancet 
Respiratory Medicine 
| Comment 
Jorge I F 
Salluh 
Fernando 
Ramos 
Jean Daniel 
Chiche 
16.06.2020 GM-CSF in the treatment of COVID-19: 
a new conductor in the pathogenesis of 
cytokine storm? 
The Lancet 
Rheumatology | 
Comment 
Ennio Giulio 
Favalli 
Roberto 
Caporali 
15.06.2020 COVID-19: rethinking risk  The Lancet Global 
Health | Comment 
Nina 
Schwalbe 
5 
Susanna 
Lehtimaki 
Juan Pablo 
Gutierrez 
June 2020 Food security in uncertain times The Lancet Planetary 
Health | Editorial 
 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
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Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health Topics   Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
7 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability 
and inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashing 
in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
8 
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
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Global Impact 
Study 
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
24-
25.06.2020 
Africa’s leadership 
role in COVID-19 
vaccine development 
and access 
Zoom webinar  African Union & Africa 
CDC 
18.06.20 2 
pm EDT 
Social, political, and 
public health factors 
fuelling the COVID19 
crisis in Brazil and 
Colombia 
Virtual event 45 mins Broad Global Health 
Initiative  
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
10 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
11 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
12 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
